Evelina Vågesjö
Director/Board Member presso LYTIX BIOPHARMA
Profilo
Evelina Wanda Matilda Vågesjö is the founder and current Chief Executive Officer of Ilya Pharma AB, which is founded in 2016.
She is also currently working as a Director at Lytix Biopharma.
AS since 2021.
Dr. Vågesjö holds a doctorate from the University of Uppsala and an MBA from Heriot-Watt University.
Posizioni attive di Evelina Vågesjö
Società | Posizione | Inizio |
---|---|---|
LYTIX BIOPHARMA | Director/Board Member | 07/06/2021 |
Ilya Pharma AB
Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Chief Executive Officer | 13/05/2016 |
Formazione di Evelina Vågesjö
University of Uppsala | Doctorate Degree |
Heriot-Watt University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LYTIX BIOPHARMA | Health Technology |
Aziende private | 1 |
---|---|
Ilya Pharma AB
Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Evelina Vågesjö